Detection of apolipoprotein E/dimeric soluble amyloid beta complexes in Alzheimer's disease brain supernatants

Biochem Biophys Res Commun. 1997 Nov 26;240(3):715-20. doi: 10.1006/bbrc.1997.7727.

Abstract

The inheritance of the apolipoprotein (apo) E4 allele is an important risk factor for late-onset Alzheimer's disease (AD). A major component of the Alzheimer's disease neuritic plaques is amyloid beta (A beta). We previously identified apoE/A beta complexes within neuritic plaques (1). It was not known if this interaction takes place before or after A beta peptides become incorporated into neuritic plaques. To address this question we sought evidence of apoE complexes with brain soluble A beta peptides in AD and control patients. In addition, numerous proteins have been shown to bind A beta peptides in vitro. It is not know if any of these bind brain sA beta in vivo. We found evidence for the presence of apoE/dimeric sA beta complexes in the AD brain and could not detect complexes with other A beta peptide binding proteins. The binding of sA beta to apoE may be one factor influencing its clearance from the brain and/or its conformational state.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alzheimer Disease / metabolism*
  • Amyloid beta-Peptides / analysis
  • Amyloid beta-Peptides / chemistry
  • Amyloid beta-Peptides / metabolism*
  • Apolipoproteins E / analysis
  • Apolipoproteins E / chemistry
  • Apolipoproteins E / metabolism*
  • Blotting, Western
  • Brain / metabolism*
  • Dimerization
  • Haplotypes
  • Humans
  • Mass Spectrometry
  • Precipitin Tests
  • Protein Binding
  • Protein Conformation
  • Solubility

Substances

  • Amyloid beta-Peptides
  • Apolipoproteins E